These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22004465)

  • 1. Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancer.
    Fagundes CP; Bennett JM; Alfano CM; Glaser R; Povoski SP; Lipari AM; Agnese DM; Yee LD; Carson WE; Farrar WB; Malarkey WB; Chen M; Kiecolt-Glaser JK
    Health Psychol; 2012 Jan; 31(1):11-9. PubMed ID: 22004465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attachment anxiety is related to Epstein-Barr virus latency.
    Fagundes CP; Jaremka LM; Glaser R; Alfano CM; Povoski SP; Lipari AM; Agnese DM; Yee LD; Carson WE; Farrar WB; Malarkey WB; Chen M; Kiecolt-Glaser JK
    Brain Behav Immun; 2014 Oct; 41():232-8. PubMed ID: 24945717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood adversity and herpesvirus latency in breast cancer survivors.
    Fagundes CP; Glaser R; Malarkey WB; Kiecolt-Glaser JK
    Health Psychol; 2013 Mar; 32(3):337-44. PubMed ID: 22746260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Perceived Stress on Epstein-Barr Virus Antibody Titers in Appalachian Ohio Women.
    Brook MJ; Christian LM; Hade EM; Ruffin MT
    Neuroimmunomodulation; 2017; 24(2):67-73. PubMed ID: 28934729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential impact of training stress and final examination stress on herpesvirus latency at the United States Military Academy at West Point.
    Glaser R; Friedman SB; Smyth J; Ader R; Bijur P; Brunell P; Cohen N; Krilov LR; Lifrak ST; Stone A; Toffler P
    Brain Behav Immun; 1999 Sep; 13(3):240-51. PubMed ID: 10469525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emotional repression, stress disclosure responses, and Epstein-Barr viral capsid antigen titers.
    Esterling BA; Antoni MH; Kumar M; Schneiderman N
    Psychosom Med; 1990; 52(4):397-410. PubMed ID: 2169064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus.
    Cacioppo JT; Kiecolt-Glaser JK; Malarkey WB; Laskowski BF; Rozlog LA; Poehlmann KM; Burleson MH; Glaser R
    Horm Behav; 2002 Aug; 42(1):32-41. PubMed ID: 12191645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I
    J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity.
    Tedeschi R; Pin E; Martorelli D; Bidoli E; Marus A; Pratesi C; Bortolin MT; Zanussi S; Vaccher E; Dolcetti R; De Paoli P
    Clin Vaccine Immunol; 2007 Apr; 14(4):435-41. PubMed ID: 17329446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
    Linde A; Andersson J; Lundgren G; Wahren B
    J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-related activation of Epstein-Barr virus.
    Glaser R; Pearson GR; Jones JF; Hillhouse J; Kennedy S; Mao HY; Kiecolt-Glaser JK
    Brain Behav Immun; 1991 Jun; 5(2):219-32. PubMed ID: 1654167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W; Cao SM; Huang QH; Li YH; Deng MQ
    Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/ethnic and socioeconomic differences in stress and immune function in The National Longitudinal Study of Adolescent Health.
    Dowd JB; Palermo T; Chyu L; Adam E; McDade TW
    Soc Sci Med; 2014 Aug; 115():49-55. PubMed ID: 24946263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus.
    Hyöty H; Räsänen L; Hiltunen M; Lehtinen M; Huupponen T; Leinikki P
    APMIS; 1991 Apr; 99(4):359-63. PubMed ID: 1645169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
    Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
    Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen.
    Persson Berg L; Thomsson E; Hasi G; Bäckström M; Bergström T
    J Virol Methods; 2020 Oct; 284():113927. PubMed ID: 32650039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.